Dynamic Process of Secondary Pulmonary Infection in Mice With Intracerebral Hemorrhage

Hanyu Zhang1,2, Yingying Huang1,2,3, Xiaojin Li1,2

  • 1College of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, China.

Frontiers in Immunology
|December 6, 2021
PubMed

Insights

Hemorrhagic stroke impairs the gut barrier and immune system, leading to bacterial migration and lung infections. Understanding this dynamic process helps identify optimal timing for interventions against post-stroke pneumonia.

Area of Science:

  • Neuroscience
  • Immunology
  • Microbiology

Background:

  • Stroke, a common CNS disease, frequently leads to infectious complications like pneumonia.
  • While gut microbiota translocation and immune dysfunction are implicated in ischemic stroke infections, mechanisms post-hemorrhagic stroke remain unclear.

Purpose of the Study:

  • To investigate immune and intestinal barrier changes after hemorrhagic stroke in mice.
  • To clarify the mechanism of secondary pulmonary infection at different time points (1, 3, and 7 days post-stroke).

Main Methods:

  • Hemorrhagic stroke model in mice.
  • Assessment of brain damage, peripheral immune status, lung tissue pathology (H&E staining, inflammatory factors).
  • Evaluation of intestinal barrier function (permeability, tight junctions, mucus, IgA) and gut microbiota (16S rRNA sequencing).

Main Results:

  • Hemorrhagic stroke caused initial brain damage followed by recovery.
  • Significant peripheral immunosuppression observed at 3 days, improving by 7 days.
  • Impaired intestinal barrier function, altered gut microbiota, and increased lung-microbiota similarity by day 7.
  • Evidence of intestinal bacteria migration to lungs, correlating with lung pathology and immune disorders.

Conclusions:

  • Hemorrhagic stroke exacerbates intestinal barrier dysfunction and immune disorders.
  • These changes promote enteric bacteria migration, increasing pneumonia risk post-stroke.
  • Findings reveal the dynamic infection process and suggest optimal intervention timing for secondary pulmonary infections.